A Phase 1 Study of RO6806127 in Healthy Male Volunteers

NCT02196636 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Placebo
DRUG: RO6806127

Sponsor

Hoffmann-La Roche